Published in Health Educ Res on August 01, 2001
Adolescents' reported reasons for alcohol and marijuana use as predictors of substance use and problems in adulthood. J Stud Alcohol Drugs (2011) 1.43
Age-related changes in reasons for using alcohol and marijuana from ages 18 to 30 in a national sample. Psychol Addict Behav (2011) 1.19
Childhood maltreatment, perceived stress, and stress-related coping in recently abstinent cocaine dependent adults. Psychol Addict Behav (2007) 1.19
An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students. Subst Use Misuse (2005) 1.12
Primary Care Patients with Drug Use Report Chronic Pain and Self-Medicate with Alcohol and Other Drugs. J Gen Intern Med (2016) 1.10
Stress-related factors in cannabis use and misuse: implications for prevention and treatment. J Subst Abuse Treat (2008) 1.07
Common stressful life events and difficulties are associated with mental health symptoms and substance use in young adolescents. BMC Psychiatry (2012) 1.05
Perceived reasons for substance misuse among persons with a psychiatric disorder. Am J Orthopsychiatry (2004) 1.03
Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience (2011) 1.01
Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior. Psychopharmacology (Berl) (2012) 0.99
"...you would probably want to do it. Cause that's what made them popular": Exploring perceptions of inhalant utility among young adolescent nonusers and occasional users. Subst Use Misuse (2009) 0.97
Effects of amphetamine on reactivity to emotional stimuli. Psychopharmacology (Berl) (2011) 0.97
Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study. BMJ (2006) 0.95
The Purpose in Chronic Addiction. AJOB Neurosci (2012) 0.95
Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. J Neural Transm (Vienna) (2007) 0.95
The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions. Am J Addict (2009) 0.94
Relief-oriented use of marijuana by teens. Subst Abuse Treat Prev Policy (2009) 0.93
Khat chewing and health related quality of life: cross-sectional study in Jazan region, Kingdom of Saudi Arabia. Health Qual Life Outcomes (2014) 0.89
Modifiable risk factors of ecstasy use: risk perception, current dependence, perceived control, and depression. Addict Behav (2009) 0.89
Social cognitive determinants of ecstasy use to target in evidence-based interventions: a meta-analytical review. Addiction (2007) 0.87
Psychopathology and the Ability to Do Otherwise. Philos Phenomenol Res (2015) 0.87
Psychosocial Attributes of Substance Abuse Among Adolescents and Young Adults: A Comparative Study of Users and Non-users. Indian J Psychol Med (2014) 0.84
Perceived Drug Use Functions and Risk Reduction Practices Among High-Risk Nonmedical Users of Prescription Drugs. J Drug Issues (2013) 0.84
Understanding recreational ecstasy use in the United States: a qualitative inquiry. Int J Drug Policy (2008) 0.84
Khat Use, PTSD and Psychotic Symptoms among Somali Refugees in Nairobi - A Pilot Study. Front Public Health (2014) 0.82
Amphetamine and cocaine suppress social play behavior in rats through distinct mechanisms. Psychopharmacology (Berl) (2013) 0.82
Influencing inhalant intentions by changing socio-personal expectations. Prev Sci (2008) 0.82
Getting higher: co-occurring drug use among marijuana-using emerging adults. J Addict Dis (2014) 0.81
Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans. Psychopharmacology (Berl) (2012) 0.81
A structured review of reasons for ecstasy use and related behaviours: pointers for future research. BMC Public Health (2009) 0.81
Endocannabinoid signaling in the etiology and treatment of major depressive illness. Curr Pharm Des (2014) 0.80
The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention. Addict Behav (2009) 0.80
Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use. Drug Alcohol Depend (2009) 0.80
Influences of motivational contexts on prescription drug misuse and related drug problems. J Subst Abuse Treat (2014) 0.79
Childhood Trauma and Illicit Drug Use in Adolescence: A Population-Based National Comorbidity Survey Replication-Adolescent Supplement Study. J Am Acad Child Adolesc Psychiatry (2016) 0.79
Episodic memories and their relevance for psychoactive drug use and addiction. Front Behav Neurosci (2013) 0.78
Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol). Psychopharmacology (Berl) (2010) 0.78
Cost benefit analysis of two policy options for cannabis: status quo and legalisation. PLoS One (2014) 0.77
Role of endocannabinoid signaling in anxiety and depression. Curr Top Behav Neurosci (2009) 0.77
Substance use in adulthood following adolescent self-harm: a population-based cohort study. Acta Psychiatr Scand (2014) 0.76
Impact of cannabis use on prefrontal and parietal cortex gyrification and surface area in adolescents and emerging adults. Dev Cogn Neurosci (2015) 0.76
Barriers to drug use behavior change among primary care patients in urban United States community health centers. Subst Use Misuse (2013) 0.76
An evolutionary perspective on the co-occurrence of social anxiety disorder and alcohol use disorder. J Affect Disord (2016) 0.75
Highs and lows: patterns of use, positive and negative effects of benzylpiperazine-containing party pills (BZP-party pills) amongst young people in New Zealand. Harm Reduct J (2007) 0.75
A Cross-Sectional Study on Selected Correlates of High risk Sexual Behavior in Polish Migrants Resident in the United Kingdom. Int J Environ Res Public Health (2017) 0.75
Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study. Am J Drug Alcohol Abuse (2016) 0.75
Substance Abuse, Relapse, and Treatment Program Evaluation in Malaysia: Perspective of Rehab Patients and Staff Using the Mixed Method Approach. Front Psychiatry (2016) 0.75
Drugs As Instruments: Describing and Testing a Behavioral Approach to the Study of Neuroenhancement. Front Psychol (2016) 0.75
Problematizing 'drugs': A cultural assessment of recreational pharmaceutical use among young adults in the US. Contemp Drug Probl (2012) 0.75
Profile of clients attending a methadone clinic. Malays J Med Sci (2015) 0.75
Early adolescents and substance use. J Addict (2012) 0.75
Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. J Subst Abuse Treat (2017) 0.75
Methadone maintenance treatment in opiate dependence: a review. BMJ (1994) 7.37
Hair analysis for drugs: technological break-through or ethical quagmire? Addiction (1993) 4.60
Drugs, HIV, and prisons. BMJ (1991) 4.52
The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction (1995) 4.02
Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues. Addiction (1993) 3.71
Surveying general practitioners: does a low response rate matter? Br J Gen Pract (1997) 3.46
Why Britain's drug czar mustn't wage war on drugs. BMJ (1997) 2.98
Alcohol and drugs. BMJ (1992) 2.97
Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. BMJ (1996) 2.76
Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction (1999) 2.72
Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet (2000) 2.72
The effect of cash and other financial inducements on the response rate of general practitioners in a national postal study. Br J Gen Pract (1997) 2.70
The heroin prescribing debate: integrating science and politics. Science (1999) 2.61
Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. BMJ (1999) 2.61
Cocaine: patterns of use, route of administration, and severity of dependence. Br J Psychiatry (1994) 2.60
Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ (1996) 2.50
The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction (1998) 2.41
Britain's new strategy for tackling drugs misuse. Shows a welcome emphasis on evidence. BMJ (1998) 2.34
Screening for hepatitis B and vaccination of injecting drug users in NHS drug treatment services. Br J Addict (1990) 2.33
Heroin overdose: the case for take-home naloxone. BMJ (1996) 2.25
Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ (2001) 2.25
Drug regimens that break a country's drug laws. BMJ (1993) 2.20
BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel. Br J Dermatol (2013) 2.17
Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict (1992) 2.13
Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry (2001) 2.01
Policy on drug misuse in Europe. BMJ (1994) 1.98
Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study. Br J Gen Pract (1999) 1.95
Harm minimisation for drug misusers. BMJ (1992) 1.91
Preseason hamstring muscle weakness associated with hamstring muscle injury in Australian footballers. Am J Sports Med (1997) 1.90
Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes. Br J Psychiatry (1989) 1.86
Chasing the dragon: characteristics of heroin chasers. Br J Addict (1988) 1.78
Mortality in meningococcal disease. BMJ (1992) 1.72
Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend (2001) 1.70
Sexual behaviour and its relationship to drug-taking among prostitutes in south London. Addiction (1994) 1.70
The general practitioner, the drug misuser, and the alcohol misuser: major differences in general practitioner activity, therapeutic commitment, and 'shared care' proposals. Br J Gen Pract (1997) 1.63
Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med (1999) 1.59
Well users clinic for illicit drug users. BMJ (1989) 1.57
A comparison of the withdrawal responses of heroin and methadone addicts during detoxification. Br J Psychiatry (1991) 1.52
Misuse of temazepam. BMJ (1988) 1.51
Suicide and overdose among opiate addicts. Addiction (1996) 1.51
Do general practitioners and general psychiatrists want to look after drug misusers? Evaluation of a non-specialist treatment policy. Br J Gen Pract (1993) 1.48
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric (2011) 1.47
Hair analysis for drugs of abuse. Lancet (1990) 1.46
Establishment of a liaison service for pregnant opiate-dependent women. Br J Addict (1992) 1.45
Sex differences in patterns of drug taking behaviour. A study at a London community drug team. Br J Psychiatry (1994) 1.44
Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction (1994) 1.44
Therapeutic drug monitoring for methadone: scanning the horizon. Eur Addict Res (1999) 1.43
Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction (2000) 1.42
Opiate detoxification under anaesthesia. BMJ (1997) 1.39
Do GPs agree with 'old' sensible drinking limits? Br J Gen Pract (1997) 1.39
Chasing the dragon. J Subst Abuse Treat (1991) 1.39
Hair analysis. New laboratory ability to test for substance use. Br J Psychiatry (1998) 1.37
Abuse of buprenorphine. Lancet (1985) 1.37
Adverse effects of stimulant drugs in a community sample of drug users. Drug Alcohol Depend (1997) 1.35
Low detection rates, negative attitudes and the failure to meet the "Health of the Nation" alcohol targets: findings from a national survey of GPs in England and Wales. Drug Alcohol Rev (1998) 1.33
A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction (1999) 1.32
Substance use among young people: the relationship between perceived functions and intentions. Addiction (1999) 1.30
Early treatment of meningococcal disease. BMJ (1992) 1.26
National survey of hepatitis testing and vaccination services provided by drug services in England and Wales. Eur J Clin Microbiol Infect Dis (2000) 1.26
Economic burden of drug dependency. Social costs incurred by drug users at intake to the National Treatment Outcome Research Study. Br J Psychiatry (1998) 1.24
Health clinics for problem drug misusers. Health Trends (1992) 1.23
Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study. AIDS Care (2002) 1.20
Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol (2009) 1.18
Study of trainer/trainee workload with special reference to the care of the elderly. J R Coll Gen Pract (1985) 1.17
Female prostitutes in south London: use of heroin, cocaine and alcohol, and their relationship to health risk behaviours. AIDS Care (1995) 1.16
Treatment retention and 1 year outcomes for residential programmes in England. Drug Alcohol Depend (1999) 1.15
Extent and nature of transitions of route among heroin addicts in treatment--preliminary data from the Drug Transitions Study. Br J Addict (1992) 1.14
Drug use and initiation in prison: results from a national prison survey in England and Wales. Addiction (2002) 1.13
Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. J Antimicrob Chemother (1991) 1.13
Directly observed treatment for tuberculosis. Could be provided by community pharmacists supervising consumption of methadone. BMJ (1996) 1.12
Utility of adjuvant systemic therapy in melanoma. Ann Oncol (2009) 1.10
Missed problems and missed opportunities for addicted doctors. BMJ (1998) 1.10
Test-retest reliability of the Severity of Dependence Scale. Addiction (1997) 1.09
Computerized tomography and neuropsychological assessment in long-term high-dose heroin addicts. Br J Addict (1989) 1.08
Duplication cysts of the esophagus. South Med J (1974) 1.06
Reductions in acquisitive crime and drug use after treatment of addiction problems: 1-year follow-up outcomes. Drug Alcohol Depend (2000) 1.06
Coherent cortical and muscle discharge in cortical myoclonus. Brain (1999) 1.05
Does post-withdrawal cue exposure improve outcome in opiate addiction? A controlled trial. Addiction (1993) 1.05
Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend (2000) 1.05
Psychiatric morbidity and substance use in young people aged 13-15 years: results from the Child and Adolescent Survey of Mental Health. Br J Psychiatry (2003) 1.05
Clinical management of spasticity. J Neurol Neurosurg Psychiatry (2005) 1.04
Illicit drugs and driving: prevalence, beliefs and accident involvement among a cohort of current out-of-treatment drug users. Drug Alcohol Depend (2000) 1.04
Tackling alcohol misuse: opportunities and obstacles in primary care. Br J Gen Pract (1998) 1.03
The differences between male and female drug users: community samples of heroin and cocaine users compared. Subst Use Misuse (1996) 1.03
Topical analgesia for superficial corneal injuries. J Accid Emerg Med (1996) 1.02
HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training. Addiction (1997) 1.02
Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study. Psychopharmacology (Berl) (2001) 1.02
Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry (2002) 1.01
Patterns of drinking and drinking outcomes among drug misusers. 1-year follow-up results. J Subst Abuse Treat (2000) 1.01
Excessive alcohol consumption and drinking expectations among clients in methadone maintenance. J Subst Abuse Treat (2001) 1.01
Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal. Drug Alcohol Depend (1997) 0.99
'Horse trading': prescribing injectable opiates to opiate addicts. A descriptive study. Drug Alcohol Rev (1992) 0.99
Methadone treatment. Only half of patients store methadone in safe place. BMJ (1996) 0.98
Changing injecting practices: blunting the needle habit. Br J Addict (1988) 0.97
Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug Alcohol Rev (1998) 0.97